HERON THERAPEUTICS, INC. /DE/ Lessee, Operating Lease, Liability, Undiscounted Excess Amount
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $280.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-10
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $280.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5.00K.
- 2025-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $24.00K.
- 2025-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $55.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $280.00K 10-Q · filed 2026-08-10 |
| 2025-09-30 | $5.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $24.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $55.00K 10-Q · filed 2025-05-06 |
| 2024-12-31 | $101.00K 10-K · filed 2025-02-27 |
| 2024-09-30 | $160.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $233.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $318.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $416.00K 10-K · filed 2024-03-12 |
| 2023-09-30 | $527.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $636.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $765.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $903.00K 10-K · filed 2023-03-29 |
| 2022-09-30 | $1.06M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.22M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.39M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.57M 10-K · filed 2022-02-28 |
| 2021-09-30 | $2.42M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $2.69M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $2.98M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $3.27M 10-K · filed 2021-02-24 |
| 2020-09-30 | $3.59M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.91M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $4.24M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $3.34M 10-K · filed 2020-03-02 |
| 2019-09-30 | $2.66M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.92M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $3.15M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |